Dual agonist for metabolic transformation.

Tirzepatide (GLP-1 T)

Peptide Class

GLP-1/GIP Dual Agonist

Primary Benefit

Weight Loss

Suggested Dose

2.5-15 mg

Dose Frequency

Once per week

Administration Method

Subcutaneous

Notes

Same day every week | Starting dose is 2.5 mg

Course Description

Tirzepatide is a dual GLP-1 and GIP receptor agonist designed for weight management and glucose control. This course explores its role in improving insulin sensitivity, reducing appetite, and promoting significant fat loss. Participants will gain a deep understanding of how Tirzepatide enhances metabolic health and supports long-term obesity treatment.

Key Learnings

Understand how Tirzepatide regulates blood sugar and appetite.
Explore its dual action on GLP-1 and GIP receptors.
Learn about its benefits in weight loss and metabolic optimization.
Examine research supporting its role in obesity treatment.
Analyze its effects on insulin sensitivity and fat metabolism.
Discover best practices for maximizing its therapeutic potential.

Who Is This Course For?

This course is ideal for healthcare professionals, metabolic researchers, and individuals looking for advanced weight loss strategies. Whether you're managing obesity or enhancing metabolic function, this course provides essential insights into Tirzepatide.